FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134712804> ?p ?o ?g. }

• W3134712804 endingPage "153541" @default.
• W3134712804 startingPage "153541" @default.
• W3134712804 abstract "Acute kidney injury (AKI), characterised by excessive inflammatory cell recruitment and programmed cell death, has a high morbidity and mortality; however, effective and specific therapies for AKI are still lacking. This study aimed to evaluate the renoprotective effects of gypenoside XLIX (Gyp XLIX) in AKI. The protective effects of Gyp XLIX were tested in two AKI mouse models established using male C57BL/6 mice (aged 6–8 weeks) by a single intraperitoneal injection of cisplatin (20 mg/kg) or renal ischemia-reperfusion for 40 min. Gyp XLIX was administered intraperitoneally before cisplatin administration or renal ischemia-reperfusion. Renal function, tubular injury, renal inflammation and programmed cell death were evaluated. In addition, the renoprotective effects of Gyp XLIX were also evaluated in cisplatin- or hypoxia-treated tubular epithelial cells. The mechanisms underlying these effects were then explored using RNA sequencing. In vivo, Gyp XLIX substantially suppressed the increase in serum creatinine and blood urea nitrogen levels. Moreover, tubular damage was alleviated by Gyp XLIX as shown by periodic acid-Schiff staining, electron microscopy and molecular analysis of KIM-1. Consistently, we found that Gyp XLIX suppressed renal necroptosis though the RIPK1/RIPK3/MLKL pathway. The anti-inflammatory and antinecroptotic effects were further confirmed in vitro. Mechanistically, RNA sequencing showed that Gyp XLIX markedly suppressed the levels of IGF binding protein 7 (IGFBP7). Co-immunoprecipitation and western blot analysis further showed that Gyp XLIX reduced the binding of IGFBP7 to IGF1 receptor (IGF1R). Additionally, picropodophyllin, an inhibitor of IGF1R, abrogated the therapeutic effects of Gyp XLIX on cisplatin-induced renal cell injury; this finding indicated that Gyp XLIX may function by activating IGF1R-mediated downstream signalling Additionally, we also detected the metabolic distribution of Gyp XLIX after injection; Gyp XLIX had a high concentration in the kidney and exhibited a long retention time. These findings may shed light on the application of Gyp XLIX for AKI treatment clinically. Gyp XLIX may serve as a potential therapeutic agent for AKI treatment via IGFBP7/ IGF1R-dependent mechanisms." @default.
• W3134712804 created "2021-03-15" @default.
• W3134712804 creator A5001221786 @default.
• W3134712804 creator A5003753200 @default.
• W3134712804 creator A5004490561 @default.
• W3134712804 creator A5021085140 @default.
• W3134712804 creator A5024283421 @default.
• W3134712804 creator A5025085694 @default.
• W3134712804 creator A5027835055 @default.
• W3134712804 creator A5034518839 @default.
• W3134712804 creator A5040833482 @default.
• W3134712804 creator A5044370298 @default.
• W3134712804 creator A5061349095 @default.
• W3134712804 creator A5063166739 @default.
• W3134712804 creator A5069967406 @default.
• W3134712804 creator A5080577523 @default.
• W3134712804 creator A5084317268 @default.
• W3134712804 date "2021-05-01" @default.
• W3134712804 modified "2023-10-02" @default.
• W3134712804 title "Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation" @default.
• W3134712804 cites W1922705469 @default.
• W3134712804 cites W1945663282 @default.
• W3134712804 cites W1971103647 @default.
• W3134712804 cites W1971799714 @default.
• W3134712804 cites W1975675341 @default.
• W3134712804 cites W1979263211 @default.
• W3134712804 cites W1980153907 @default.
• W3134712804 cites W1980942307 @default.
• W3134712804 cites W1981240182 @default.
• W3134712804 cites W1985914009 @default.
• W3134712804 cites W1993085845 @default.
• W3134712804 cites W2002312823 @default.
• W3134712804 cites W2028164091 @default.
• W3134712804 cites W2035846842 @default.
• W3134712804 cites W2041808638 @default.
• W3134712804 cites W2042615771 @default.
• W3134712804 cites W2043664888 @default.
• W3134712804 cites W2044251727 @default.
• W3134712804 cites W2051032666 @default.
• W3134712804 cites W2056496966 @default.
• W3134712804 cites W2065737867 @default.
• W3134712804 cites W2069840256 @default.
• W3134712804 cites W2076990941 @default.
• W3134712804 cites W2078209296 @default.
• W3134712804 cites W2082355794 @default.
• W3134712804 cites W2087627594 @default.
• W3134712804 cites W2089171551 @default.
• W3134712804 cites W2101800432 @default.
• W3134712804 cites W2106240866 @default.
• W3134712804 cites W2106389533 @default.
• W3134712804 cites W2166687975 @default.
• W3134712804 cites W2171175193 @default.
• W3134712804 cites W2233632661 @default.
• W3134712804 cites W2243229544 @default.
• W3134712804 cites W2289115148 @default.
• W3134712804 cites W2289863162 @default.
• W3134712804 cites W2371948111 @default.
• W3134712804 cites W2437452430 @default.
• W3134712804 cites W2461826943 @default.
• W3134712804 cites W2767924566 @default.
• W3134712804 cites W2774318362 @default.
• W3134712804 cites W2784035183 @default.
• W3134712804 cites W2793299871 @default.
• W3134712804 cites W2892878753 @default.
• W3134712804 cites W2898473057 @default.
• W3134712804 cites W2931725810 @default.
• W3134712804 cites W2935350940 @default.
• W3134712804 cites W2962190192 @default.
• W3134712804 cites W2967330386 @default.
• W3134712804 cites W2982433954 @default.
• W3134712804 cites W3000348771 @default.
• W3134712804 cites W3005595012 @default.
• W3134712804 cites W3010611079 @default.
• W3134712804 cites W3038896507 @default.
• W3134712804 doi "https://doi.org/10.1016/j.phymed.2021.153541" @default.
• W3134712804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33773190" @default.
• W3134712804 hasPublicationYear "2021" @default.
• W3134712804 type Work @default.
• W3134712804 sameAs 3134712804 @default.
• W3134712804 citedByCount "14" @default.
• W3134712804 countsByYear W31347128042021 @default.
• W3134712804 countsByYear W31347128042022 @default.
• W3134712804 countsByYear W31347128042023 @default.
• W3134712804 crossrefType "journal-article" @default.
• W3134712804 hasAuthorship W3134712804A5001221786 @default.
• W3134712804 hasAuthorship W3134712804A5003753200 @default.
• W3134712804 hasAuthorship W3134712804A5004490561 @default.
• W3134712804 hasAuthorship W3134712804A5021085140 @default.
• W3134712804 hasAuthorship W3134712804A5024283421 @default.
• W3134712804 hasAuthorship W3134712804A5025085694 @default.
• W3134712804 hasAuthorship W3134712804A5027835055 @default.
• W3134712804 hasAuthorship W3134712804A5034518839 @default.
• W3134712804 hasAuthorship W3134712804A5040833482 @default.
• W3134712804 hasAuthorship W3134712804A5044370298 @default.
• W3134712804 hasAuthorship W3134712804A5061349095 @default.
• W3134712804 hasAuthorship W3134712804A5063166739 @default.
• W3134712804 hasAuthorship W3134712804A5069967406 @default.
• W3134712804 hasAuthorship W3134712804A5080577523 @default.

• next